PharVision Advisers »

Apellis Pharmaceuticals shares owned by PharVision Advisers

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $504k 22k 22.63

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Morgan Stanley
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
Jennison Associates
State Street Corporation
EcoR1 Capital
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors

View all funds holding Apellis Pharmaceuticals